Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - OTHER OPERATING ACTIVITIES
Other Operating Activities ITCI - Intra-Cellular Therapies, Inc.
-8.31 M
LAST VALUE
-589.45%
2 YEAR CAGR
56.44%
5 YEAR CAGR
-36.36%
10 YEAR CAGR